MarkEdwinZafereoJr.MDFACS

Head & Neck Oncologic Surgery

MD Anderson Cancer Center

Dr. Zafereo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1515 Holcombe Blvd Unit 1445
Md Anderson Cancer Center Dept Head And Neck Surgery
Houston, TX 77030
Phone+1 713-792-6525

Dr. Mark Zafereo is an Associate Professor of Head and Neck Surgery at MD Anderson Cancer Center in Houston, Texas. He is Section Chief of Head and Neck Endocrine Surgery and Associate Medical Director of the Endocrine Center at MD Anderson Cancer Center. Dr. Zafereo holds national committee appointments for the American Head and Neck Society, American Academy of Otolaryngology-Head and Neck Surgery, and American Thyroid Association, and American College of Surgeons, and he is a Past President of the Houston Society of Otolaryngology-Head and Neck Surgery. He has published extensively on Thyroid and other Head & Neck cancers, speaking nationally and internationally. His clinical practice focuses on patients afflicted with thyroid cancer and parathyroid neoplasms.

University of Texas Health Science Center at HoustonFellowship, Otolaryngology - Head and Neck Surgery, 2010 - 2011
Baylor College of MedicineResidency, Otolaryngology - Head and Neck Surgery, 2007 - 2010
University of Texas Health Science Center at HoustonResidency, Otolaryngology - Head and Neck Surgery, 2005 - 2007
University of Texas Health Science Center at HoustonInternship, Transitional Year, 2005 - 2006
McGovern Medical School at UTHealthClass of 2005

PubMed

Definitive Radiotherapy for Oligometastatic and Oligoprogressive Thyroid Cancer: A Potential Strategy for Systemic Therapy Deferral.
Stephanie O Dudzinski, Maria E Cabanillas, Sarah Hamidi, Vicente R Marczyk, Naifa L Busaidy
Journal of the National Comprehensive Cancer Network. 2024-12-11
Efficacy and Safety of Selective RET Inhibitors in Patients with Advanced Hereditary Medullary Thyroid Carcinoma.
Sarah Hamidi, Sireesha Yedururi, Mimi I Hu, Naifa L Busaidy, Steven I Sherman
Thyroid. 2024-12-04
Polygenic Score for Clinicopathologic Features and Survival Outcomes in Papillary Thyroid Carcinoma.
Sophie Li, Guibin Zheng, Li Xu, Maitrayee Goswami, Mark E Zafereo
JAMA Otolaryngology-- Head & Neck Surgery. 2024-11-27

Journal Articles

International Neural Monitoring Study Group Guideline 2018 Part I: Staging Bilateral Thyroid Surgery with Monitoring Loss of Signal
Gregory W Randolph, Gayle Woodson, Mark Zafereo, Whitney Liddy, Peter Angelos, Lisa Orloff, Louise Davies, Jennifer J Shin, Joseph Scharpf, Richard J Wong, Emad Kandil..., The Laryngoscope
Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive Iodine
Thinh Vu, Naifa L Busaidy, Maria E Cabanillas, Steven G Waguespack, Steven I Sherman, Mark Zafereo, The Journal of Clinical Endocrinology and Metabolism

Preview of the 93rd American Thyroid Association Annual MeetingJuly 1st, 2024
His Thyroid Cancer Was Too Rare for Doctors to Treat. After a Trial, Woodlands Man Now Cancer-FreeDecember 14th, 2022
Thyroid Cancer Survivor: MD Anderson Took Me from Hospice to HopeJanuary 22nd, 2019
Join now to see all